Experimental data demonstrated that PAQR5 promotes HCC cell proliferation, invasion, and EMT by activating the NF-κB signaling pathway, with regulatory effects on p65 phosphorylation and NF-κB activation mediated via the ERK pathway. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.